Furthermore, DHA increased the anti-pancreatic cancer effects of gemcitabine by inactivating NF-κB both in vitro and in vivo [18] and suppressed angiogenesis by regulating the NF-κB pathway [15]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.